|
|
|
|
|
|
|
|
|
|
|
|
Protein Info
|
|
|
|
|
|
Short Name:
|
MOK
|
|
Full Name:
|
MOK protein kinase
|
|
Alias:
|
EC 2.7.11.22; RAGE; RAGE1
|
|
Type:
|
Protein-serine kinase, CMGC group, RCK family
|
|
Mass (Da):
|
48014
|
|
Number AA:
|
419
|
|
UniProt ID:
|
Q9UQ07
|
|
International Prot ID:
|
IPI00413657
|
|
Sequence:
|
Retrieve full protein sequence
|
|
|
|
|
GO Terms
|
|
External Links
|
Internal Links
|
|
|
|
|
|
Cellular Component:
|
GO:0005737
|
Uniprot
|
OncoNet
|
|
Molecular Function:
|
GO:0005524
GO:0004693
GO:0005515
|
PhosphoSite+
|
KinaseNET
|
|
|
Biological Process:
|
GO:0006468
GO:0007165
|
Phosida
|
TranscriptoNet
|
|
|
|
|
STRING
|
Kinexus Products
MAPK-MAK-MRK overlapping kinase; MOK protein kinase pan-specific antibody AB-NK281-1#http://www.kinexusproducts.ca/ProductInfo_Antibody.aspx?Product_Number=AB-NK281-1#MAPK-MAK-MRK overlapping kinase; MOK protein kinase T159+Y161 phosphosite-specific antibody AB-PK720#http://www.kinexusproducts.ca/ProductInfo_Antibody.aspx?Product_Number=AB-PK720#MAPK-MAK-MRK overlapping kinase; MOK protein kinase Y167 phosphosite-specific antibody AB-PK721#http://www.kinexusproducts.ca/ProductInfo_Antibody.aspx?Product_Number=AB-PK721#MAPK-MAK-MRK overlapping kinase / MOK protein kinase (E287-G303, human) peptide - Powder PE-01BEB85#http://www.kinexusproducts.ca/ProductInfo_Peptide.aspx?Product_Number=PE-01BEB85#MAPK-MAK-MRK overlapping kinase / MOK protein kinase (C388-Q407, human) peptide - Powder PE-01BEC90#http://www.kinexusproducts.ca/ProductInfo_Peptide.aspx?Product_Number=PE-01BEC90#MAPK-MAK-MRK overlapping kinase / MOK protein kinase (Q156-S163, human) pT159+pY161 phosphopeptide - Powder PE-04ABB90#http://www.kinexusproducts.ca/ProductInfo_Peptide.aspx?Product_Number=PE-04ABB90#MAPK-MAK-MRK overlapping kinase / MOK protein kinase (S163-P170, human) pY167 phosphopeptide - Powder PE-04ABC85#http://www.kinexusproducts.ca/ProductInfo_Peptide.aspx?Product_Number=PE-04ABC85#MAPK-MAK-MRK overlapping kinase / MOK protein kinase (Q156-P170, human) pT159+pY161+pT164+pY167 phosphopeptide - Powder PE-04AWM75#http://www.kinexusproducts.ca/ProductInfo_Peptide.aspx?Product_Number=PE-04AWM75
|
|
|
|
|
Info Box
|
|
A variety of parameters were considered in the selection of putative P-sites.
Confirmed P-Sites have lower Hydrophobicity Scores. The P-site Similarity Score
is lower the more that it resembles typical confirmed corresponding P-Ser, P-Thr
or P-Tyr sites. The Maximum KInase Score provides the calculated score for
highest match of 500 human protein kinases for the amino acid sequence
surrounding the target P-site as determined with Kinase Substrate Predictor V2.
The Sum KInase Score provides the additive sum of the positive individual Kinase
Substrate Predictor V2 scores from 500 human protein kinases. The Conservation
Score is the average of the percent similarity of the human P-site with the
equivalent P-site in 20 other diverse species. Click the coloured buttons below
to retrieve this and other information in the Info Box, or click the orange
buttons for relevant links. |
|
| Phosphosites | |
| |
| | | -7 | -6 | -5 | -4 | -3 | -2 | -1 | 0 | 1 | 2 | 3 | 4 | 5 | 6 | 7 | | Expt. conf. | Effect | Kinase | PPase | Kinexus Products | | Ref. | Evol. | Kinase Pred. | P-site Match |
| | Site 1 | S16 | K | I | G | E | G | T | F | S | E | V | M | K | M | Q | S | |  |  | | | | | |  | | |
| | Site 2 | S23 | S | E | V | M | K | M | Q | S | L | R | D | G | N | Y | Y | | | | | | | | | | | |
| | Site 3 | Y29 | Q | S | L | R | D | G | N | Y | Y | A | C | K | Q | M | K | |  | | | | | | | | | |
| | Site 4 | Y30 | S | L | R | D | G | N | Y | Y | A | C | K | Q | M | K | Q | | | | | | | | | | | |
| | Site 5 | S41 | Q | M | K | Q | R | F | E | S | I | E | Q | V | N | N | L | | | | | | | | | | | |
| | Site 6 | S75 | E | V | V | F | D | R | K | S | G | S | L | A | L | I | C | | | | | | | | | | | |
| | Site 7 | S77 | V | F | D | R | K | S | G | S | L | A | L | I | C | E | L | | | | | | | | | | | |
| | Site 8 | Y90 | E | L | M | D | M | N | I | Y | E | L | I | R | G | R | R | | | | | | | | | | | |
| | Site 9 | Y98 | E | L | I | R | G | R | R | Y | P | L | S | E | K | K | I | | | | | | | | | | | |
| | Site 10 | S101 | R | G | R | R | Y | P | L | S | E | K | K | I | M | H | Y | | | | | | | | | | | |
| | Site 11 | Y108 | S | E | K | K | I | M | H | Y | M | Y | Q | L | C | K | S | | | | | | | | | | | |
| | Site 12 | Y110 | K | K | I | M | H | Y | M | Y | Q | L | C | K | S | L | D | | | | | | | | | | | |
| | Site 13 | S148 | L | K | L | G | D | F | G | S | C | R | S | V | Y | S | K | | | | | | | | | | | |
| | Site 14 | S151 | G | D | F | G | S | C | R | S | V | Y | S | K | Q | P | Y | | | | | | | | | | | |
| | Site 15 | Y153 | F | G | S | C | R | S | V | Y | S | K | Q | P | Y | T | E | | | | | | | | | | | |
| | Site 16 | S154 | G | S | C | R | S | V | Y | S | K | Q | P | Y | T | E | Y | | | | | | | | | | | |
| | Site 17 | Y158 | S | V | Y | S | K | Q | P | Y | T | E | Y | I | S | T | R | | | | | | | | | | | |
| | Site 18 | T159 | V | Y | S | K | Q | P | Y | T | E | Y | I | S | T | R | W | | | | | |  MAPK-MAK-MRK overlapping kinase; MOK protein kinase T159+Y161 phosphosite-specific antibody AB-PK720#http://www.kinexusproducts.ca/ProductInfo_Antibody.aspx?Product_Number=AB-PK720#MAPK-MAK-MRK overlapping kinase / MOK protein kinase (Q156-S163, human) pT159+pY161 phosphopeptide - Powder PE-04ABB90#http://www.kinexusproducts.ca/ProductInfo_Peptide.aspx?Product_Number=PE-04ABB90#MAPK-MAK-MRK overlapping kinase / MOK protein kinase (Q156-P170, human) pT159+pY161+pT164+pY167 phosphopeptide - Powder PE-04AWM75#http://www.kinexusproducts.ca/ProductInfo_Peptide.aspx?Product_Number=PE-04AWM75 | | | | | |
| | Site 19 | Y161 | S | K | Q | P | Y | T | E | Y | I | S | T | R | W | Y | R | | | | | | MAPK-MAK-MRK overlapping kinase; MOK protein kinase T159+Y161 phosphosite-specific antibody AB-PK720#http://www.kinexusproducts.ca/ProductInfo_Antibody.aspx?Product_Number=AB-PK720#MAPK-MAK-MRK overlapping kinase / MOK protein kinase (Q156-S163, human) pT159+pY161 phosphopeptide - Powder PE-04ABB90#http://www.kinexusproducts.ca/ProductInfo_Peptide.aspx?Product_Number=PE-04ABB90#MAPK-MAK-MRK overlapping kinase / MOK protein kinase (Q156-P170, human) pT159+pY161+pT164+pY167 phosphopeptide - Powder PE-04AWM75#http://www.kinexusproducts.ca/ProductInfo_Peptide.aspx?Product_Number=PE-04AWM75 | | | | | |
| | Site 20 | T164 | P | Y | T | E | Y | I | S | T | R | W | Y | R | A | P | E | | | | | | MAPK-MAK-MRK overlapping kinase / MOK protein kinase (Q156-P170, human) pT159+pY161+pT164+pY167 phosphopeptide - Powder PE-04AWM75#http://www.kinexusproducts.ca/ProductInfo_Peptide.aspx?Product_Number=PE-04AWM75 | | | | | |
| | Site 21 | Y167 | E | Y | I | S | T | R | W | Y | R | A | P | E | C | L | L | | | | | | MAPK-MAK-MRK overlapping kinase; MOK protein kinase Y167 phosphosite-specific antibody AB-PK721#http://www.kinexusproducts.ca/ProductInfo_Antibody.aspx?Product_Number=AB-PK721#MAPK-MAK-MRK overlapping kinase / MOK protein kinase (S163-P170, human) pY167 phosphopeptide - Powder PE-04ABC85#http://www.kinexusproducts.ca/ProductInfo_Peptide.aspx?Product_Number=PE-04ABC85#MAPK-MAK-MRK overlapping kinase / MOK protein kinase (Q156-P170, human) pT159+pY161+pT164+pY167 phosphopeptide - Powder PE-04AWM75#http://www.kinexusproducts.ca/ProductInfo_Peptide.aspx?Product_Number=PE-04AWM75 | | | | | |
| | Site 22 | T175 | R | A | P | E | C | L | L | T | D | G | F | Y | T | Y | K | | | | | | | | | | | |
| | Site 23 | Y181 | L | T | D | G | F | Y | T | Y | K | M | D | L | W | S | A | | | | | | | | | | | |
| | Site 24 | S245 | D | F | P | F | K | K | G | S | G | I | P | L | L | T | T | | | | | | | | | | | |
| | Site 25 | T291 | Y | F | Q | E | Q | R | K | T | E | K | R | A | L | G | S | | | | | | | | | | | |
| | Site 26 | S298 | T | E | K | R | A | L | G | S | H | R | K | A | G | F | P | | | | | | | | | | | |
| | Site 27 | S315 | P | V | A | P | E | P | L | S | N | S | C | Q | I | S | K | | | | | | | | | | | |
| | Site 28 | S317 | A | P | E | P | L | S | N | S | C | Q | I | S | K | E | G | | | | | | | | | | | |
| | Site 29 | S321 | L | S | N | S | C | Q | I | S | K | E | G | R | K | Q | K | | | | | | | | | | | |
| | Site 30 | S330 | E | G | R | K | Q | K | Q | S | L | K | Q | E | E | D | R | | | | | | | | | | | |
| | Site 31 | Y345 | P | K | R | R | G | P | A | Y | V | M | E | L | P | K | L | | | | | | | | | | | |
| | Site 32 | S362 | S | G | V | V | R | L | S | S | Y | S | S | P | T | L | Q | | | | | | | | | | | |
| | Site 33 | Y363 | G | V | V | R | L | S | S | Y | S | S | P | T | L | Q | S | | | | | | | | | | | |
| | Site 34 | S365 | V | R | L | S | S | Y | S | S | P | T | L | Q | S | V | L | | | | | | | | | | | |
| | Site 35 | T367 | L | S | S | Y | S | S | P | T | L | Q | S | V | L | G | S | | | | | | | | | | | |
| | Site 36 | S370 | Y | S | S | P | T | L | Q | S | V | L | G | S | G | T | N | | | | | | | | | | | |
| | Site 37 | S374 | T | L | Q | S | V | L | G | S | G | T | N | G | R | V | P | | | | | | | | | | | |
| | Site 38 | S392 | P | L | K | C | I | P | A | S | K | K | T | D | P | Q | K | | | | | | | | | | | |
| | Site 39 | T412 | P | Q | Q | C | R | L | P | T | I | V | R | K | G | G | R | | | | | | | | | | | |
|
|
|
|
|
|
|
|
Legend
|
|
|
|
Confirmed in mammals
|
|
Confirmed in related proteins or other species
|
|
|
Predicted by Kinexus P-Site Prediction algorithm
|
|
|
No data/link available
|
|
|
Link available
|
|
|
Products available
|
|
|
|
|
|
|
|
|
|
2019 Kinexus Bioinformatics Corporation
|
|